Biogenic amines and their metabolites in mouse brain tissue: development, optimization and validation of an analytical HPLC method.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2010-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jchromb.2010.09.019PMID 20934393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurobiology of Alzheimer’s Disease (Molecular and Cellular Neurobiology)

  2011cited by this paper
• Protein Quantification at the Single Vesicle Level Reveals That a Subset of Synaptic Vesicle Proteins Are Trafficked with High Precision

  2011cited by this paper
• Fast analysis of catecholamine metabolites MHPG and VMA in human plasma by HPLC with fluorescence detection and a novel SPE procedure.

  2009cited by this paper
• Traitement de la maladie de Parkinson en 2009.

  2009cited by this paper
• [Management of Parkinson's disease in 2009].

  2009cited by this paper
• Laboratory guide to the methods in biochemical genetics

  2008cited by this paper
• The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.

  2008cited by this paper
• Neuropathology and therapeutic management of Alzheimer's disease - An update

  2008cited by this paper
• Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. Examples of application.

  2008cited by this paper
• Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies

  2007cited by this paper
• Determination of highly polar catecholamine with liquid chromatography–tandem mass spectrometry using weak cation-exchange stationary phase to increase retention time

  2007cited by this paper
• Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part III.

  2007cited by this paper
• Dementia management in France

  2006cited by this paper
• Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies

  2006cited by this paper
• Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.

  2006cited by this paper
• Sleep disturbance, norepinephrine, and D-dimer are all related in elderly caregivers of people with Alzheimer disease.

  2006cited by this paper
• Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.

  2006cited by this paper
• Dose dependent effect of APOE ε4 on behavioral symptoms in frontal lobe dementia

  2006cited by this paper
• The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease

  2005cited by this paper
• Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain

  2005cited by this paper
• Parkinson's disease and neurotransmitters interplay in processes of neurotoxicity and oxidative stress in On and Off phenomena

  2004cited by this paper
• Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part II.

  2004cited by this paper
• Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice

  2004cited by this paper
• Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.

  2004cited by this paper
• Functional neurochemistry of Alzheimer's disease.

  2004cited by this paper
• Functional Neurochemistry of Alzheimers Disease

  2004cited by this paper
• Analysis of plasma catecholamines by liquid chromatography with amperometric detection using a novel SPE ion-exchange procedure

  2003cited by this paper
• Development of highly selective and sensitive determination methods for catecholamines

  2003cited by this paper
• Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression.

  2003cited by this paper
• Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report)

  2002cited by this paper
• Practice parameter: Initiation of treatment for Parkinson’s disease: An evidence-based review

  2002cited by this paper
• Oxalic acid stabilizes dopamine, serotonin, and their metabolites in automated liquid chromatography with electrochemical detection.

  2001cited by this paper
• Simultaneous determination of catecholamines in rat brain tissue by high-performance liquid chromatography.

  1999cited by this paper
• Determination ofm-xylylenediamine in the official EU food simulant olive oil

  1999cited by this paper
• Current Neurotransmitter Strategies in AD Drug Development

  1998cited by this paper
• m-Xylylenediamine determination in the official EU aqueous food simulants.

  1998cited by this paper
• Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.

  1998cited by this paper
• The neurochemistry of Alzheimer's disease.

  1997cited by this paper
• High-Performance Liquid Chromatographic Determination of Catecholamines, Serotonin and Their Metabolites with Three-Potential Electrochemical Detection

  1996cited by this paper
• Prediction of precision from signal and noise measurement in liquid chromatography: Limit of detection

  1995cited by this paper
• Simultaneous Automated Determination of Catecholamines, Serotonin, and Their Metabolites in Brain Tissue by HPLC and Electrochemical Detection

  1993cited by this paper
• Determination of the catecholamines and serotonin, their precursors tyrosine and tryptophan, and their main metabolites in rat brain using reversed-phase high-performance liquid chromatography with fluorimetric and oxidative amperometric detection in series.

  1992cited by this paper
• High-performance liquid chromatographic analysis of catecholamines in biological samples by liquid/liquid extraction prepurification.

  1990cited by this paper
• High-performance liquid chromatographie analysis of catecholamines in biological samples by liquid/liquid extraction prepurification

  1990cited by this paper
• Simultaneous determination of catecholamines and serotonin by liquid chromatography, after treatment with boric acid gel.

  1988cited by this paper
• Combined ion-pair extraction and high-performance liquid chromatography for the determination of the biogenic amines and their major metabolites in single brain tissue samples.

  1987cited by this paper
• Simultaneous HPLC Analysis of Catecholamines and Indoleamines in Mouse Brain Tissue Following Acetate Extraction and Treatment with Ascorbate Oxidase

  1987cited by this paper
• Ascorbic acid as an antioxidant in measurements of catecholamines in plasma.

  1987cited by this paper
• Alzheimer's disease and serotonin: a review.

  1986cited by this paper
• Determination of dopamine, norepinephrine, serotonin and their major metabolic products in rat brain by reverse-phase ion-pair high performance liquid chromatography with electrochemical detection.

  1985cited by this paper
• Study of the electrooxidative behaviour of 5-hydroxyindole-3-acetic acid, 5-hydroxytryptophan and serotonine in the presence of sodium ethylenediaminetetraacetic acid

  1984cited by this paper
• Determination of L-tyrosine in rat brain by reversed-phase liquid chromatography with electrochemical detection.

  1983cited by this paper
• Neurochemical studies on catecholamines and indoleamines by high-performance liquid chromatography with electrochemical detection

  1982cited by this paper
• Determination of rat brain tissue catecholamines using liquid chromatography with electrochemical detection.

  1981cited by this paper
• Determination of dopa, dopamine, dopac, epinephrine, norepinephrine, alpha-monofluoromethyldopa and alpha-difluoromethyldopa in various tissues of mice and rats using reversed-phase ion-pair liquid chromatography with electrochemical detection.

  1979cited by this paper
• Ultramicro method for the determination of picogram amounts of norepinephrine and epinephrine by high-performance liquid chromatography.

  1979cited by this paper
• DETERMINATION OF CATECHOLAMINES IN RAT BRAIN PARTS BY REVERSE‐PHASE ION‐PAIR LIQUID CHROMATOGRAPHY

  1978cited by this paper
• An Electrochemical Detector for Liquid Chromatography with Picogram Sensitivity

  1973cited by this paper
• The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.

  1972cited by this paper
• A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas.

  1971cited by this paper
• A method for the estimation of the catecholamines and their metabolites in brain tissue

  1970cited by this paper

• Ultra performance liquid chromatography with ultrasound assisted magnetic ionic liquid dispersive liquid liquid microextraction for determination of 20 neurotransmitters in spinal cords

  2025cites this paper
• Analysis of Biogenic Amines and Small Molecule Metabolites in Human Diabetic Wound Ulcer Exudate

  2024cites this paper
• Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of neurotransmitters in rat brain tissue exposed to 4'-Fluoro-α-PHP.

  2022cites this paper
• Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease

  2021cites this paper
• Pharmacological Activity of Dried Kernels of Juglans regia on Ovotoxicity Induced Post-Menopausal Complications in Female Rats

  2020cites this paper
• Co-administration of TiO2-nanowired dl-3-n-butylphthalide (dl-NBP) and mesenchymal stem cells enhanced neuroprotection in Parkinson's disease exacerbated by concussive head injury.

  2020cites this paper
• Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease.

  2019cites this paper
• A review of pretreatment and analytical methods of biogenic amines in food and biological samples since 2010.

  2019cites this paper
• Design of Experiments in metabolomics‐related studies: An overview

  2019cites this paper
• Sensitive determination of monoamine neurotransmitters, their main metabolites and precursor amino acids in different mouse brain components by liquid chromatography-electrospray tandem mass spectrometry after selective sample clean-up.

  2019cites this paper
• Analytical methods used in the study of Parkinson's disease

  2019cites this paper
• The Combined Neuropharmacology and Toxicology of Major 'Bath Salts' Constituents MDPV, Mephedrone, and Methylone

  2018cites this paper
• Comprehensive analysis of nine monoamines and metabolites in small amounts of peripheral murine (C57Bl/6 J) tissues.

  2018cites this paper
• Simultaneous determination of 10 kinds of biogenic amines in rat plasma using high-performance liquid chromatography coupled with fluorescence detection.

  2018cites this paper
• Abnormal levels of seven amino neurotransmitters in depressed rat brain and determination by HPLC-FLD.

  2017cites this paper
• ALEXYS Neurotransmitter Analyzer for Monoamines and their Acidic Metabolites

  2017cites this paper
• A simple and sensitive high-performance liquid chromatography-electrochemical detection assay for the quantitative determination of monoamines and respective metabolites in six discrete brain regions of mice.

  2017influential citation
• Development, validation and application of mass spectrometry methods for clinical pharmacokinetics, neurotransmitter and human habitat studies

  2016cites this paper
• Simultaneous determination of 8 neurotransmitters and their metabolite levels in rat brain using liquid chromatography in tandem with mass spectrometry: Application to the murine Nrf2 model of depression.

  2016cites this paper
• Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice

  2016influential citation
• Simultaneous determination of eleven compounds related to metabolism of bioamines in rat cortex and hippocampus by HPLC-ECD with boron-doped diamond working electrode.

  2016cites this paper
• Title : Simultaneous quanti fi cation of monoamine neurotransmitters and their biogenic metabolites intracellularly and extracellularly in primary neuronal cell cultures and in sub-regions of guinea pig brain

  2016influential citation
• Simultaneous quantification of monoamine neurotransmitters and their biogenic metabolites intracellularly and extracellularly in primary neuronal cell cultures and in sub-regions of guinea pig brain.

  2016cites this paper
• An HPLC-ECD method for monoamines and metabolites quantification in cuttlefish (cephalopod) brain tissue.

  2016cites this paper
• Simultaneous determination of 14 biogenic amines and metabolites in bullfrog blood using UFLC-MS/MS with SPE

  2015cites this paper
• Measuring levels of biogenic amines and their metabolites in rat brain tissue using high-performance liquid chromatography with photodiode array detection

  2015cites this paper
• Effective HPLC method development

  2015cites this paper
• Full Length Research Article ANALYTICAL QUALITY BY DESIGN (AQBD): NEW PARADIGM FOR ANALYTICAL METHOD DEVELOPMENT

  2015cites this paper
• Determination of neurotransmitters and their metabolites using one- and two-dimensional liquid chromatography with acidic potassium permanganate chemiluminescence detection

  2014cites this paper
• HPLC METHOD DEVELOPMENT AND VALIDATION: AN OVERVIEW

  2014cites this paper
• Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue.

  2014cites this paper
• Fast Mimicking of Phase 1 and 2 Metabolism of Acetaminophen using the ROXY™ EC System difference

  2014cites this paper
• Robust Applications , Fluidly Running Alexys Neurotransmitter Analyzer for Monoamines and Metabolites

  2014cites this paper
• Oxidative Metabolism of Amodiaquine using the ROXY™ EC System Discover the

  2014cites this paper
• Analysis of microdialysate monoamines, including noradrenaline, dopamine and serotonin, using capillary ultra-high performance liquid chromatography and electrochemical detection.

  2014cites this paper
• Brain Region-Specific Monoaminergic Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease

  2014cites this paper
• Factorial-Based Designs in Liquid Chromatography

  2013cites this paper
• HPLC method development and validation- an overview

  2013cites this paper
• Analysis of glutamate, GABA, noradrenaline, dopamine, serotonin, and metabolites using microbore UHPLC with electrochemical detection.

  2013cites this paper
• Quantitation of dopamine, serotonin and adenosine content in a tissue punch from a brain slice using capillary electrophoresis with fast-scan cyclic voltammetry detection.

  2013cites this paper
• Profiling analysis of biogenic amines and their acidic metabolites in mouse brain tissue using gas chromatography-tandem mass spectrometry.

  2013cites this paper
• Assessment the effect of NO inhibition on hippocampal serotonin level and compare it with the stress condition in adult male rat

  2013cites this paper
• Experimental design in chromatography: a tutorial review.

  2012cites this paper
• Factorial-Based Designs in Liquid Chromatography

  2012influential citation
• Optimizing a chromatographic three component separation: a comparison of mechanistic and empiric modeling approaches.

  2012cites this paper
• A Comprehensive Overview Of HPLC Method Development And Validation

  year unknowncites this paper